Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BUPIVACAINE vs BUPRENORPHINE\NALOXONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BUPIVACAINE vs BUPRENORPHINE\NALOXONE: Safety Overview

Metric BUPIVACAINE BUPRENORPHINE\NALOXONE
Total FAERS Reports 11,356 21,631
Deaths Reported 466 1,119
Death Rate 4.1% 5.2%
Hospitalizations 2,367 2,872
Average Patient Age 50.5 yrs 40.3 yrs
% Female Patients 68.1% 49.1%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Sportpharm LLC N/A
Route EPIDURAL N/A
Marketing Status Prescription N/A